Key result
hs-TnT improves myocardial necrosis detection but requires in-depth clinical assessment for AMI diagnosis.
Answers are grounded in this paper and cite their sources.
Elevated highly sensitive troponin T levels require careful clinical correlation to accurately diagnose acute myocardial infarction and guide therapy in NSTE-ACS.
The presence of the cardiospecific cardiac troponins (cTns) I (cTnI) and T (cTnT) alongside signs or symptoms of myocardial infarction (MI) are indicative of an acute MI. As these proteins are not typically found in the sera of healthy individuals, any concentration of cTns exceeding the 99th percentile is interpreted as myocardial necrosis. Recently, new cTnI and cTnT with increased sensitivity and precision have been introduced to improve the detection and diagnosis of acute MI, the newest of which, the Elecsys® Troponin T highly sensitive assay, has demonstrated a particular advantage with high precision even in the 99th percentile. These enhanced properties are expected to increase the incidence of MI diagnoses, but currently it is not clear how to approach therapy in response to the detection of cTnT levels. The detection of elevated cTn levels alone is not sufficient for a diagnosis of acute MI, and requires an in-depth assessment of clinical presentation to determine the source and severity of myocardial damage.
No takes yet. Share an insight, caveat, or question.
Giannitsis et al. (2009) conducted a review in Non-ST-segment-elevation Acute Coronary Syndrome. Highly Sensitive Troponin T Assay was evaluated. The highly sensitive Troponin T assay improves detection of myocardial necrosis, but elevated levels require in-depth clinical assessment for an acute myocardial infarction diagnosis.
Synapse has enriched 10 related papers. Consider them for comparative context: